Determination of gabapentin in human plasma using hydrophilic interaction liquid chromatography with tandem mass spectrometry

被引:42
作者
Ji, Hye Young
Jeong, Dong Won
Kim, Young Hoon
Kim, Hui-Hyun
Yoon, Yoo-Seok
Lee, Kang Choon
Lee, Hye Suk [1 ]
机构
[1] Wonkwang Univ, Coll Pharm, Drug Metab & Bioanal Lab, Iksan 570749, South Korea
[2] Wonkwang Univ, Phytofermentat Res Ctr, Iksan 570749, South Korea
[3] Sungkyunkwan Univ, Coll Pharm, Drug Target Lab, Suwon 440746, South Korea
关键词
D O I
10.1002/rcm.2573
中图分类号
Q5 [生物化学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
A rapid, sensitive and selective method for the determination of gabapentin in human plasma was developed using hydrophilic interaction liquid chromatography/tandem mass spectrometry (HILIC/MS/MS). The devised method involved protein precipitation with acetonitrile followed by separation on an Atlantis HILIC silica column using an acetonitrile/ammonium formate mobile phase (100 mM, pH 3.0) (85:15, v/v). Analytes were detected using an electrospray ionization mass spectrometer in the multiple-reaction monitoring mode. The standard curve was linear (r = 1.000) over the concentration range of 50.0-10000ng/mL. The lower limit of quantification for gabapentin was 50.0 ng/mL (ca. 20pg gabapentin) using a 10-mu L plasma sample. The coefficients of variation and relative errors for intra- and inter-assay at four QC levels (i.e., 50.0, 125, 750, and 7500 ng/mL) were 4.7 to 9.4% and -4.1 to 1.6%, respectively. Absolute and relative matrix effects for gabapentin and metformin were practically absent. Gabapentin and metformin recoveries were 98.5% and 99.0%, respectively. This method was successfully applied to a bioequivalence study of gabapentin in humans. Copyright (c) 2006 John Wiley & Sons, Ltd.
引用
收藏
页码:2127 / 2132
页数:6
相关论文
共 45 条
[1]
ABDULRAHMAN A, 2005, J LIQ CHROM RELAT TE, V28, P3119
[2]
Backonja Misha-Miroslav, 2003, Current Neuropharmacology, V1, P199, DOI 10.2174/1570159033477062
[3]
Quantitative determination of vigabatrin and gabapentin in human serum by gas chromatography-mass spectrometry [J].
Borrey, DCR ;
Godderis, KO ;
Engelrelst, VIL ;
Bernard, DR ;
Langlois, MR .
CLINICA CHIMICA ACTA, 2005, 354 (1-2) :147-151
[4]
Sample preparation and determination of gabapentin in venous and capillary blood using liquid chromatography-tandem mass spectrometry [J].
Carlsson, KC ;
Reubsaet, JLE .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2004, 34 (02) :415-423
[5]
CHENG JK, 2006, IN PRESS J PHARM SCI
[6]
Fast isocratic high-performance liquid chromatographic assay method for the simultaneous determination of gabapentin and vigabatrin in human serum [J].
Chollet, DF ;
Goumaz, L ;
Juliano, C ;
Anderegg, G .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2000, 746 (02) :311-314
[7]
CHUNG TC, 2006, IN PRESS J CHROMAT A
[8]
Liquid/liquid extraction using 96-well plate format in conjunction with hydrophilic interaction liquid chromatography-tandem mass spectrometry method for the analysis of fluconazole in human plasma [J].
Eerkes, A ;
Shou, WZ ;
Weng, ND .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2003, 31 (05) :917-928
[9]
Determination of gabapentin in plasma by high-performance liquid chromatography [J].
Forrest, G ;
Sills, GJ ;
Leach, JP ;
Brodie, MJ .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1996, 681 (02) :421-425
[10]
Gas chromatography-tandem mass spectrometry analysis of gabapentin in serum [J].
Gambelunghe, C ;
Mariucci, G ;
Tantucci, M ;
Ambrosini, MV .
BIOMEDICAL CHROMATOGRAPHY, 2005, 19 (01) :63-67